- Patent Title: 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors
-
Application No.: US16469071Application Date: 2017-12-07
-
Publication No.: US11001570B2Publication Date: 2021-05-11
- Inventor: Steffen Steurer , Georg Dahmann , Nina Kerres , Manfred Koegl
- Applicant: Boehringer Ingelheim International GmbH , Felix Paul Kerres
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH,Felix Paul Kerres
- Current Assignee: Boehringer Ingelheim International GmbH,Felix Paul Kerres
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Philip I. Datlow
- Priority: EP16203746 20161213
- International Application: PCT/EP2017/081899 WO 20171207
- International Announcement: WO2018/108704 WO 20180621
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/415 ; C07D401/14 ; A61P35/00 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D491/113 ; C07D498/08
Abstract:
The present invention encompasses compounds of formula (I), wherein the groups R1 to R5, X, Y and W have the meanings given in the claims and specification, their use as inhibitors of BCL6, pharmaceutical compositions which contain compounds of this kind and their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases.
Public/Granted literature
- US20200071297A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS Public/Granted day:2020-03-05
Information query
